Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2006-09-19
2006-09-19
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S227800, C514S232200, C514S235500, C514S254010, C514S326000, C514S343000, C514S397000, C514S422000, C514S423000, C544S058500, C544S060000, C544S082000, C544S141000, C544S372000, C546S208000, C546S278700, C548S112000, C548S314700, C548S427000, C548S517000, C548S537000
Reexamination Certificate
active
07109186
ABSTRACT:
The present invention describes novel compounds of Formula I which inhibit HIV integrase. The invention also describes compositions and treatments of AIDS or ARC by using these compounds
REFERENCES:
patent: 6727275 (2004-04-01), Zou et al.
patent: WO 02/070491 (2002-09-01), None
patent: WO 03/016266 (2003-02-01), None
patent: WO 03/016275 (2003-02-01), None
patent: WO 03/035076 (2003-05-01), None
patent: WO 03/035077 (2003-05-01), None
Banville Jacques
Ma Zhuping
Naidu B. Narasimhulu
Pendri Annapurna
Plamondon Serge
Bernhardt Emily
Bristol--Myers Squibb Company
Epperson James
LandOfFree
HIV integrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HIV integrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV integrase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3595544